We are live on ! Find out more
WMGI

Wright Medical Group Inc
WMGI

Delisted

WMGI was delisted on the 10th of November, 2020.

167 hedge funds and large institutions have $2.6B invested in Wright Medical Group Inc in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 51 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 51

3% less funds holding

Funds holding: 173167 (-6)

15% less capital invested

Capital invested by funds: $3.05B → $2.6B (-$449M)

17% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 36

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

93% less call options, than puts

Call options by funds: $504K | Put options by funds: $7.52M

Holders
167
Holders Change
-6
Holders Change %
-3.47%
% of All Funds
3.79%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
30
Increased
61
Reduced
51
Closed
36
Calls
$504K
Puts
$7.52M
Net Calls
-$7.02M
Net Calls Change
-$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$349M -$79.9K -3,241 -0%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$230M +$18.5M +748,520 +8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$194M +$4.93M +199,758 +2%
BlackRock
4
BlackRock
New York
$161M +$2.37M +96,142 +1%
O
5
OrbiMed
New York
$152M -$51.6M -2,094,166 -23%
Capital Research Global Investors
6
Capital Research Global Investors
California
$86.9M +$13.3M +537,500 +16%
JP Morgan Chase
7
JP Morgan Chase
New York
$81.3M -$5.33K -216 -0%
Invesco
8
Invesco
Georgia
$68.6M -$13M -528,324 -15%
Fisher Asset Management
9
Fisher Asset Management
Washington
$63.1M -$1.17M -47,572 -2%
UBS AM
10
UBS AM
Illinois
$61.9M +$785K +31,828 +1%
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$61.6M +$7.01M +284,208 +11%
PAI
12
Palo Alto Investors
California
$60.7M +$1.48M +59,900 +2%
Westfield Capital Management
13
Westfield Capital Management
Massachusetts
$56.9M -$1.44M -58,585 -2%
Bank of America
14
Bank of America
North Carolina
$53.6M +$6.83M +277,064 +13%
State Street
15
State Street
Massachusetts
$47.5M +$2.09M +84,600 +4%
BM
16
Bridger Management
New York
$44.9M -$13.1M -532,915 -21%
Axa
17
Axa
France
$41.7M +$39.4M +1,598,074 +574%
Northern Trust
18
Northern Trust
Illinois
$40.1M -$665K -26,979 -1%
Macquarie Group
19
Macquarie Group
Australia
$34.3M +$3.85M +156,093 +11%
Deutsche Bank
20
Deutsche Bank
Germany
$33.2M -$16.2M -657,988 -31%
GKIM
21
GW&K Investment Management
Massachusetts
$30M -$3.95M -159,968 -11%
Loomis, Sayles & Company
22
Loomis, Sayles & Company
Massachusetts
$29.8M +$510K +20,670 +2%
Goldman Sachs
23
Goldman Sachs
New York
$28.5M -$23.5K -953 -0.1%
Wells Fargo
24
Wells Fargo
California
$23.4M -$16M -650,200 -38%
PCM
25
Peregrine Capital Management
Minnesota
$21.9M +$153K +6,202 +0.6%

WMGI Hedge Fund Activity: Q4 2017 in Review

167 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Wright Medical Group Inc (WMGI) for Q4 2017, worth a combined $2.6B — down 15% from $3.05B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of WMGI and 30 opened new positions — a net loss of 6 holders — while 51 trimmed existing stakes and 61 added.

The largest buyer was Axa, adding an estimated $39.4M. The largest seller was OrbiMed, cutting an estimated $51.6M.

  • 167 institutional investors held Wright Medical Group Inc (WMGI) as of Q4 2017, down from 173 in Q3 2017.
  • Funds reported $2.6B of Wright Medical Group Inc stock for Q4 2017, down 15% quarter-over-quarter.
  • 30 funds opened new Wright Medical Group Inc positions in Q4 2017 and 36 closed out, a net change of -6 holders.
  • The largest Wright Medical Group Inc buyer in Q4 2017 was Axa, an estimated $39.4M added.
  • The largest Wright Medical Group Inc seller in Q4 2017 was OrbiMed, an estimated $51.6M sold.

Based on aggregated 13F filings for Q4 2017.